These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 7004740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin II and sodium as determinants of the agonistic--antagonistic balance of saralasin's actions.
    Fagard R, Amery A, Lijnen P.
    Clin Sci (Lond); 1981 Apr; 60(4):377-85. PubMed ID: 7018793
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E, Brown JJ, Brown WC, Fraser R, Trust PM, Lever AF, Morton JJ, Robertson JI.
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [Abstract] [Full Text] [Related]

  • 7. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
    Beckerhoff R, Uhlschmid G, Vetter W, Armbruster H, Nussberger J, Reck G, Schmied U, Siegenthaler W.
    Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
    [Abstract] [Full Text] [Related]

  • 8. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R, Lijnen P, Amery A, Reybrouck T.
    Contrib Nephrol; 1978 Jun; 11():175-8. PubMed ID: 699588
    [Abstract] [Full Text] [Related]

  • 9. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Jun; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II blockade in normal subjects and essential hypertensive patients.
    MacGregor GA, Dawes PM.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():193s-196s. PubMed ID: 1071606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rate of activation of renin-angiotensin-aldosterone axis and sodium intake in rats.
    Holtzman E, Braley LM, Menachery A, Williams GH, Hollenberg NK.
    Am J Physiol; 1989 May; 256(5 Pt 2):H1311-5. PubMed ID: 2655479
    [Abstract] [Full Text] [Related]

  • 13. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
    Hata T, Ogihara T, Nakamaru M, Gotoh S, Masuo K, Saeki S, Kumagai A, Kumahara Y.
    Eur J Clin Pharmacol; 1982 May; 23(1):7-10. PubMed ID: 6751836
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P, Donker AJ, Leenen FH.
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [Abstract] [Full Text] [Related]

  • 15. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
    Wallace JM, Case DB, Laragh JH, Keim HJ, Drayer JI, Sealey JE.
    Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH, Tan SY, Mulrow PJ.
    J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH, Amery AK, Lijnen PJ, Reybrouck TM.
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [Abstract] [Full Text] [Related]

  • 18. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
    McGrath BP, Ledingham JG, Benedict CR.
    Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
    [Abstract] [Full Text] [Related]

  • 19. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.